Skip to main content
. 2021 Mar 11;6(1):e25574. doi: 10.2196/25574

Table 1.

Study participants’ characteristics.

Characteristics IV/UCa (n=59) UC/IVb (n=60) P value
Age (years), mean (SD) 56.1 (11.1) 57.4 (12.1) .55
Age (years), n (%) .56
  18-40 5 (8) 4 (7) c
  40-65 42 (71) 39 (65)
  65+ 12 (20) 17 (28)
Gender (women), n (%) 34 (58) 29 (48) .36
Race, n (%) .65
  White 40 (68) 45 (75)
  Black 6 (10) 3 (5)
  Native/Alaskan American 1 (2) 0 (0)
  More than 1 race 7 (12) 6 (10)
  Not reported 5 (8) 6 (10)
Ethnicity, n (%) .81
  Hispanic Latinx 11 (19) 9 (15)
  Not Hispanic Latinx 46 (78) 48 (80)
  Not reported 2 (3) 3 (5)
Education, n (%) .80
  <High school grad 9 (15) 7 (12)
  High school grad 18 (31) 17 (28)
  Post–high school trade 6 (10) 5 (8)
  1-3 years college 14 (24) 16 (27)
  College grad 11 (19) 13 (22)
  Not reported 1 (2) 2 (3)
Household income (US$), n (%) .78
  <20k 24 (41) 22 (37)
  20-50k 11 (19) 14 (23)
  50-100k 10 (17) 11 (18)
  >100k 11 (19) 7 (12)
  Not reported 3 (5) 6 (10)
Internet access, n (%) .73
  No 9 (15) 11 (18)
  Yes 50 (85) 47 (78)
  Not reported 0 (0) 2 (3)
Insulin use, n (%) .62
  No 7 (12) 9 (15)
  Yes 52 (88) 51 (85)
HbA1cd %, mean (SD) 10.3 (1.4) 10.0 (1.4) .21
Treatment satisfaction [14], mean (SD) 29.6 (5.3) 28.4 (5.2) .24

aIV/UC: intervention for 6 months before usual care for 6 months.

bUC/IV: usual care for 6 months before intervention for 6 months.

cNot available.

dHbA1c: hemoglobin A1c.